Home Merck dives into 'superbug' chase with Cubist
 

Keywords :   


Merck dives into 'superbug' chase with Cubist

2014-12-08 17:23:28| Biotech - Topix.net

Merck will spend $8.4 billion to buy Cubist Pharmaceuticals and push deeper into treating so-called "superbugs" that have drawn dire warnings from global health organizations. The company said Monday that the deal will give it stronger footing in hospital acute care and help it address antibiotic resistance, which the Whitehouse Station, New Jersey, drugmaker called a critical area of unmet medical need.

Tags: chase merck dives cubist

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »